Cite
MLA Citation
E. Ong et al.. “Dramatic improvement after rituximab in a patient with paraneoplastic treatment‐refractory Morvan syndrome associated with anti‐CASPR2 antibodies.” European journal of neurology, vol. 20, no. 7, n.d., pp. e96–e97. http://access.bl.uk/ark:/81055/vdc_100024481977.0x000048